17β-estradiol (E2) and estrogen receptor (ER) signaling could protect against HCC, not only by triggering this caspase-1-dependent mechanism, but also by inhibiting the beneficious effects of autophagy in tumoral cells [165]. The gene discussed is ESR1; the disease is hepatocellular carcinoma.